The following is a summary of “Thyroid function during COVID-19 and post-COVID complications in adults: a systematic review,” ...

Without digital distractions, children seem to experience more profound awe, emphasizing the importance of creating ...

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

Fibromun is under clinical development by Philogen and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...

An estimated 13.8 million people in the U.S. will have Alzheimer’s disease (AD) by 2050, two thirds of whom are projected to ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Currently, Namodenoson is being evaluated in a pivotal Phase 3 multinational registrational trial for the treatment of ...

INR:8784. mastercard bet365 Innovative therapy targeting dual inflammation-related cytokine pathways received FDA breakthrough therapy designation After GMP, GC ...

INR:1750. matka 143 Innovative therapy targeting dual inflammation-related cytokine pathways received FDA breakthrough therapy designation Yifeng Pharmacy invests in se ...

The surge in cases of cancer in the under-50s has made many of us worry, with bowel, breast and lung cancers among those ...

INR:8758. which app is best for watching football live Innovative therapy targeting dual inflammation-related cytokine pathways recei ...

double bed design The overseas rights of Aisen Biopharma's third-generation EGFR-TKI "Avitinib" were sold after failing to obtain the first domestically produced Innovative therapy targeting dual ...